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Abstract
Cell therapy represents a promising therapeutic for a myriad of medical conditions, including 
cancer, traumatic brain injury, and cardiovascular disease among others. A thorough 
understanding of the efficacy and cellular dynamics of these therapies necessitates the ability to 
non-invasively track cells in vivo. Magnetic resonance imaging (MRI) provides a platform to track 
cells as a non-invasive modality with superior resolution and soft tissue contrast. We recently 
reported a new nanoprobe platform for cell labeling and imaging using fluorophore doped siloxane 
core nanoemulsions as dual modality (1H MRI/Fluorescence), dual-functional (oximetry/
detection) nanoprobes. Here, we successfully demonstrate the labeling, dual-modality imaging, 
and oximetry of neural progenitor/stem cells (NPSCs) in vitro using this platform. Labeling at a 
concentration of 10 μl/104 cells with a 40%v/v polydimethylsiloxane core nanoemulsion, doped 
with rhodamine, had minimal effect on viability, no effect on migration, proliferation and 
differentiation of NPSCs and allowed for unambiguous visualization of labeled NPSCs by 1H MR 
and fluorescence and local pO2 reporting by labeled NPSCs. This new approach for cell labeling 
with a positive contrast 1H MR probe has the potential to improve mechanistic knowledge of 
current therapies, and guide the design of future cell therapies due to its clinical translatability.
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INTRODUCTION
Neural progenitor/stem cell (NPSC) transplants have shown promise in the context of 
neurodegenerative disease, stroke and traumatic injury within the central nervous system, 
making NPSC cell therapy an attractive candidate for translation to the clinic11. However, 
the mechanisms behind the benefits of NPSC therapies and their safety and efficacy remain 
unclear11. Evidence of this can be found in early clinical trials investigating fetal-derived 
neural stem cell grafts as a therapy for Parkinson’s disease. While acute data indicated a 
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recovery of dopaminergic neuronal function24, long-term success was highly variable. These 
trials were discontinued as many cases developed dyskinesia and two resulted in patient 
death23. As such, effective NPSC labeling for tracking transplants through clinically 
relevant, non-invasive imaging becomes necessary in looking towards a mechanistic 
understanding of cell-based therapies and their translation to the clinic. Effective methods to 
non-invasively track transplanted cells have the capacity to 1) understand the mechanism of 
existing therapies and 2) promote innovation and improvement of therapies currently in 
development.
Magnetic resonance imaging (MRI) is a widely used and extremely versatile clinical 
diagnostic tool because 1. it is non-invasive, 2. has no tissue depth penetration limitation at 
clinical fields and 3. provides both contrast among soft tissues at reasonably high spatial 
resolution and functional information related to tissue micro-architecture. The emergence of 
novel contrast agents (e.g. super-paramagnetic iron oxide or SPIO nanoparticles, micron-
sized iron oxide particles or MPIOs and perfluorocarbon nanoparticles) has recently made 
possible in vivo real-time cell tracking with MRI30. The added benefit of superior soft tissue 
contrast of the underlying anatomy characteristic of MRI, allows for improvement in the 
accuracy of implant localization and visualization. However, the sensitivity of 1H MRI is 
lower than other modalities particularly for cellular detection in vivo and is affected by 
several factors that are intrinsic to MRI such as the pulse sequence under consideration, coil 
geometry and sensitivity, optimal choice of scan parameters, and the field strength and 
homogeneity.
Many laboratories have investigated the feasibility of using conventional 1H MRI to 
visualize immune cells, stem cells, and other cell types as reviewed recently21,29,30. 
Pioneering work with iron-oxide labeling visualized the presence and distribution of 
transplanted cells with negative contrast MRI (i.e. transplanted cells appear darker than 
background tissue)8,13,16 as well as positive contrast (transplanted cells appear brighter than 
background tissue)9,12. Recent work also used 19F based nanoprobes3,5–7,28 to successfully 
label cells with a 19F MRI contrast agent (perfluorocarbon (PFC) nanoemulsion) prior to 
transplantation, enabling simultaneous visualization of the disease pathology, tissue 
regeneration and transplanted cells via a dual 19F/1H approach with no background signal. 
Moreover, PFCs may also serve as an oxygen reporter thereby significantly expanding the 
capacity of MRI to report real-time molecular insight for cell therapy innovation17. 
However, wide use of 19F MRI for routine human clinical application remains challenging, 
as most existing clinical scanners in hospitals cannot be easily modified to include 19F MR 
capability. Even for dedicated research scanners, adding 19F MR capability could involve 
expensive upgrades to hardware, software, and dual-tuned/wide-band tunable coils. As such, 
our efforts focused on developing a non-invasive cell tracking method that utilizes chemical-
shift based positive signal contrast 1H MRI to facilitate clinical translation.
We previously reported on Proton Imaging of Siloxanes to Map Tissue Oxygenation Levels 
(PISTOL), a technique that both tracks siloxanes and siloxane based nanoemulsions as MR 
positive contrast agents (via their unique chemical shift at 0 ppm) and also reports local pO2 
levels using 1H MRI15,18,20,24. While our previous application of PISTOL focused on cancer 
diagnostic/prognostic technologies, the benefit of applying this reporter probe and the 
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associated imaging technique to cell transplant strategies is very self-evident. The 
nanoemulsion platform lends itself to incorporation of hydrophobic fluorescent dyes to 
enable dual MR and fluorescent imaging modalities24 for in vivo imaging and ex vivo 
analysis. Therefore, this labeling paradigm has the potential to be a valuable tool from bench 
to clinic.
Neural progenitor/stem cell populations (NPSCs) are of specific interest to use as a 
benchmark transplant cell type as NPSC transplants have shown promise in 
neurodegenerative and traumatic brain injury models11,27. Magneto-dendrimers, SPIO and 
MPIO particles have been used in the past to label NPSCs with success9,13,16; however, iron 
oxide particle-labeled cells display a negative contrast signal much larger in volume than the 
implanted cell volume and are also susceptible to false positives in detection due to the 
characteristic MR signal voids of injured and neurodegenerative environments.
In this study, we investigated the behavior of NPSCs upon labeling with PDMS-core 
nanoemulsions loaded with a hydrophobic fluorophore and demonstrated dual-modality (1H 
MR/fluorescence) imaging of labeled cells in vitro. In particular, we investigated the effect 
of labeling on NPSC proliferation, migration and differentiation, and all in vitro imaging 
studies were designed with future in vivo applicability in mind.
MATERIALS AND METHODS
Nanoparticle synthesis
Siloxane-based nanopropbes were synthesized as nanoemulsions based on our previously 
reported methods15,24, with the use of polydimethylsiloxane (PDMS)/rhodamine B instead 
of hexamethylsiloxane (HMDSO)/Nile red as MR reporter/fluorophore, respectively. 
Briefly, nanoprobes were composed of PDMS/rhodamine B solution (40% v/v), deionized 
water (55% v/v) and Solutol® HS 15 (BASF Inc, Florham Park, NJ) as surfactant (5% v/v).
The PDMS/rhodamine B solution was prepared by dissolving a rhodamine-lipid conjugate 
(Lissamine Rhodamine B PE, Avanti Polar Lipids, Inc., Alabaster, AL) in chloroform 
(Sigma Aldrich, St. Louis, MO), subsequently heating to 40°C for 1 hr. PDMS (410 g/mol; 
Alfa Aesar, Ward Hill, MA) was then added and this solution was maintained under vacuum 
at 60 °C for 12 hrs to remove excess chloroform and yield a 0.25 mM rhodamine solution in 
PDMS. HS 15 was heated to a liquid state before mixing with deionized water (DIH2O) in a 
1:11 ratio at 70°C for 2 minutes. PDMS/rhodamine solution was then added drop-wise to the 
DIH2O/HS 15 solution and allowed to sit at 70°C for 15 minutes prior to sonication for 45 
minutes (3×15 minute intervals at 150W with a duty cycle of 50%) using a Omniruptor 4000 
Ultrasonic Homogenizer (Omni International, Tulsa, OK). Nanoemulsions were filtered 
through 0.22 μm pore syringe filters 11 times prior to particle size measurement. The final 
concentration of Rhodamine B was 0.1 mM in the nanoemulsion. Nanoparticle diameter was 
characterized by Dynamic Light Scattering (DLS) (Delsa Nano Particle Size Analyzer, 
Beckman Coulter, Pasadena, CA), and mean diameter was obtained from 8 nanoemulsion 
samples.
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NPSC isolation and culture
Neural progenitor/stem cells (NPSCs) were harvested from the medial and lateral germinal 
eminences of C57/BL6 E14.5 fetal mice according to protocols approved by the Arizona 
State University Institutional Animal Care and Use Committee. Briefly, mice were 
anesthetized at 3% isoflurane, rapidly decapitated, and fetuses were extracted from both 
uterine horns. Fetal tissue was rinsed in sterile, cold Leibovitz medium (Life Technologies, 
Carlsbad, CA) at each stage of the germinal eminence dissection. The germinal eminences 
were rinsed with sterile, cold Leibovitz medium before mechanical dissociation in working 
NPSC medium (glucose (6 ng/mL, Acros Organics, Geel, Belgium), HEPES buffer (5 mM, 
Sigma Aldrich, St. Louis, MO), progesterone (62.9 ng/mL, Sigma Aldrich), putrescine (9.6 
μg/mL, Sigma Aldrich), heparin (1.83 μg/mL, Sigma Aldrich), B27 growth supplement (1X, 
Life Technologies), epidermal growth factor (20 ng/mL, Sigma Aldrich), fibroblast growth 
factor (5 ng/mL, Sigma Aldrich), insulin (5 μg/mL, Sigma Aldrich), transferrin (5 μg/mL, 
Sigma Aldrich), sodium selenite (5 ng/mL, Sigma Aldrich) in Dulbecco’s Modified Eagle 
Medium (Life Technologies))and plated at a density of 104 cells/mL in a humidified 
incubator at 37°C, 20% O2, and 5% CO2. NPSCs were cultured as non-adherent 
neurospheres in working NPSC medium, passaged by mechanical dissociation, and utilized 
for experiments between passages 3 through 6.
NPSC Labeling and Viability
NPSC labeling was optimized with respect to viability by flow cytometry (BD Accuri C6, 
BD Biosciences, Franklin Lakes, NJ) where NPSCs in culture as neurospheres (3 × 105 cells 
per group) were supplemented with nanoparticle suspension at 1, 5, 10 or 50 μL/104 cells 
and incubated in humid conditions at 37°C for 1 hr. Following incubation, NPSCs were 
rinsed with fresh media prior to staining with calcein AM to label live NPSCs. For flow 
cytometry analysis of positive calcein AM, NPSCs were then spun down, rinsed with fresh 
media, and re-suspended at 105 cells/μL in sterile PBS + 0.1% bovine serum albumin (104 
events counted per group). For fluorescence microscopy analysis, 100 μL NPSC suspension 
was pipetted onto a microscope slide and cover-slipped prior to imaging (DMI 6000B, Leica 
Microsystems, Wetzlar, Germany). Based on data presented in Figure 2 and Supplementary 
Figure 1, the 10 μL/104 cells labeling condition provided sufficient labeling with minimal 
impact on NPSC viability and was therefore used for subsequent experiments.
Effect of labeling on NPSC behavior
Proliferation—Labeled and unlabeled neurospheres were plated on poly-l-lysine (PLL) in 
48-well plates (n=6, 10 μg/cm2 PLL; MP Biomedicals, Solon, OH) at a density of 25 
neurospheres/cm2. After 6 days of culture in NPSC growth medium, NPSCs were digested 
in proteinase K solution for 72 hrs at 37°C and double-stranded DNA (dsDNA) was isolated 
with the Qiagen DNeasy kit (Qiagen, Venlo, Limburg, Netherlands). Quantification of 
dsDNA was performed by the Quant-iT PicoGreen dsDNA assay (Life Technologies) 
according to manufacturer’s protocol and used as a measure of NPSC proliferation after 
normalizing to baseline measurements taken at the time of plating.
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Migration—Labeled NPSCs and unlabeled NPSC controls were plated in ECM coated 24-
well plates at 25 neurospheres/cm2 (n=4 replicates per group; poly-L-lysine or laminin-1 (6 
μg/cm2; Sigma Aldrich), in mitogenic growth factor-free NPSC media. Cultures were 
imaged via phase contrast microscopy at 1, 3 and 6 days allowing for the tracking of radial 
NPSC migration out of the neurosphere. Images (n=6 per sample well) were analyzed for 
longest sphere diameter as shown in Figure 4 using a custom-designed MATLAB program 
(MathWorks, Inc., Natick, MA) and were normalized to baseline measurements taken 2 
hours after plating.
Differentiation—Labeled and unlabeled neurospheres were cultured on laminin-1 coated 
glass coverslips as described previously in 24-well plates (n=4 replicates per group) for 6 
days. NPSCs were then fixed with 3.7% paraformaldehyde (Sigma Aldrich), permeabilized 
with 0.1% Triton X 100 (Fisher Scientific, Houston, TX), and probed for proteins indicative 
of astrocytes (mouse anti-GFAP, Millipore, Billerica, MA), young neurons (mouse anti-β III 
Tubulin, Millipore), NPSCs (rabbit anti-nestin, Abcam, Cambridge, UK), and 
oligodendrocytes (rabbit anti-Olig2, Millipore). AlexaFluor488-conjugated goat anti-rabbit 
(Life Technologies) and AlexaFluor647-conjugated goat anti-mouse (Life Technologies) 
secondaries were used appropriately. DAPI (Life Technologies) was used for visualization 
of cell nuclei. Samples were imaged at 20X magnification via fluorescence microscopy (n=3 
images per well; Leica, DMI4000 B).
Dual modality imaging of labeled NPSCs
All MR imaging was performed on a pre-clinical Bruker 7T scanner (Bruker, Billerica, MA) 
and the fluorescence imaging was performed using an IVIS-Spectrum instrument 
(PerkinElmer, Waltham, MA), both at the Barrow Neurological Institute-Arizona State 
University Center for Preclinical Imaging (Barrow Neurological Institute, Phoenix, AZ). 
Standard curves were generated based on known oxygenation levels (0, 10, and 21% O2) at 
23°C and 33.5 °C and used to calibrate PDMS nanoemulsion longitudinal relaxation rate, R1 
= 1/T1, where T1 is the longitudinal relaxation time, as a function of pO2. NPSCs were 
labeled and 3 different imaging phantoms were prepared for dual modality MR/fluorescence 
imaging. The standard imaging protocol involved acquisition of T1 and T2 weighted scout 
scans to visualize the phantom, siloxane selective imaging using the PISTOL sequence 20 
with proton density weighting to visualize the labeled NPSCs within the phantom. The MR 
imaging parameters employed were: FOV = 3×3 cm2, TR/TE = 1000/25 ms, 64×64 matrix, 
slice thickness = 5 mm, in plane spatial resolution = 0.47×0.47 mm/pixel, scan time of 1s. 
Rhodamine selective fluorescence imaging (λex/λem: 500 nm/560 nm) was performed to 
image the fluorophore label.
In the first phantom, a 750μL base layer of 2% agar was placed in the 2.0 mL 
microcentrifuge tube and placed on ice for cooling. Following gelation, 1.0 mL of labeled 
NPSC suspension (4×105 cells/mL, 1 hr labeling time) was added on top of the base layer 
and centrifuged at 1000 rpm for 5 minutes, forming a pellet on top of the agarose layer. A 
second 1.0 mL layer of liquid agarose was then gently pipetted on top of the cell pellet. This 
phantom was designed to simulate the scenario post-injection of a NPSC cell pellet in vivo.
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A second imaging phantom was prepared using slightly different labeling parameters with 
an aim to increase labeling payload. Using 950,000 cells and a 3 hr incubation time, NPSCs 
were labeled. Instead of immersing the labeled pellet in two layers of agar, the NPSCs were 
washed in DPBS and re-suspended using 100 μL of agarose. This phantom was designed to 
replicate the injection of a NPSC loaded scaffold in vivo.
Finally a third phantom was made with the same procedure as phantom #1 (1 hr labeling 
time) with 105 cells (4 times less than phantom #1) to assess the sensitivity of the technique 
with our existing MR coils. This was then imaged using magnetic resonance spectroscopic 
imaging (MRSI, also referred to as chemical shift imaging or CSI) in addition to the 
standard imaging protocol described earlier. The MRSI acquisition parameters were: 
sequence= 2D point resolved spectroscopy (PRESS) based CSI, TR/TE = 1500/60 ms, FOV 
= 3×3 cm2, 16×16×2048 matrix, spectral width = 4006 Hz, slice thickness = 4 mm, 1 
average, in plane spatial resolution= 1.875×1.875 mm/pixel, spectral resolution = 0.98 Hz/
pts, total scan time =6 min 24 s. A siloxane image was created from the MRSI data using 
MATLAB by integrating under the siloxane peak at every voxel, and overlaid on a scout 
image to display the location of NPSCs within the phantom. The 1H resonance from PDMS 
is located at 0 ppm, (~1425 Hz up-field from water at 7T) on chemical shift spectra, similar 
to that of hexamethyldisiloxane18. Additionally, pO2 was mapped with the PISTOL 
sequence by varying TR and number of averages as described in ref 20. The acquired T1 
weighted PISTOL images subsequently fit offline in MATLAB™ on a pixel-by-pixel basis 
using a custom built routine to generate the pO2 map from the measured R1 vs. pO2 
calibration curve (Supplementary Figure 3).
Statistical Analysis
All statistical analysis was performed in Prism 6 (GraphPad Software Inc., La Jolla, CA). 
NPSC proliferation data was analyzed by two-tailed t-test using Welch’s correction for 
unequal standard deviations and α=0.05. NPSC migration data was analyzed by two-way 
ANOVA with Tukey’s posthoc test and α=0.05. Flow cytometry analysis was performed in 
FlowJo (Tree Star Inc., Ashland, OR) where equivalent gating was performed for all 
samples.
RESULTS
Nanoemulsion labels NPSCs while maintaining viability
The nanoemulsion particle size was on an appropriate scale for cellular uptake, ranging from 
50 – 150 nm and mean diameter of 98 ± 28 nm (Figure 1). Doping the nanoemulsions with 
the hydrophobic dye rhodamine B-PE facilitated fluorescent monitoring of cell labeling in 
vitro (Figure 2, Supplementary Figure 2). Flow cytometry data yielded a calcein AM-
negative dead cell population (gating illustrated in Supplementary Figure 1), which 
increased as a function of labeling concentration. NPSC viability was maintained over 94% 
at 1 μL/104 cells, maintained over 80% at 5 and 10 μL/104 cells, then dropped to 64.60% at 
50 μL/104 cells (Figure 2A). The two lowest labeling concentrations (1 and 5 μL/104 cells, 
Figure 2B, C) did not label NPSCs with detectable fluorescence intensity as observed with 
conventional fluorescence microscopy to enable distinction between labeled and unlabeled 
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NPSCs. Effective NPSC labeling was observed by fluorescence microscopy at the two 
higher concentrations (10 and 50 μL/104 cells, Figure 2D, E). Based on these data, 10 
μL/104 cells labeling concentration provided the most effective labeling with minimal 
detriment to NPSC viability and, as such, was used for all subsequent experiments.
Labeling does not significantly affect NPSC proliferation
NPSC proliferation after 6 days in culture conditions was not significantly different between 
labeled and unlabeled populations (p = 0.095, Figure 3) as determined by PicoGreen dsDNA 
quantification. The unlabeled NPSC population was observed to increase by 1.12 ± 0.21 × 
104 cells where labeled NPSCs increased 1.31 ± 0.21 × 104 cells compared to baseline 
measurements taken 2 hours after plating.
Labeling does not significantly affect NPSC migration
Labeled and unlabeled NPSC radial migration significantly increased on laminin compared 
to PLL at both days 3 and 6 (p<0.001 for both, Figure 4B, C). Moreover, there was no 
significant difference between labeled and unlabeled NPSC migration at 3 or 6 days on 
either PLL (p=0.9979, 0.9993, respectively) or laminin substrates (p=0.9163, 0.8901, 
respectively). It is important to note that the actively migrating cells from the central 
neurosphere at both days 3 and 6 remained labeled (Supplementary Figure 2), providing 
qualitative evidence that labeling does not negatively affect NPSC migration.
Labeling does not significantly affect NPSC differentiation
NPSC capacity for differentiation into young neurons, astrocytes and oligodendrocytes was 
not negatively affected by labeling after 6 days of culture on laminin (Figure 5). Labeled and 
unlabeled NPSCs stained positive at comparable levels for GFAP, a marker for astrocytes 
(Figure 5B, E), Olig2, a marker for young oligodendrocytes (Figure 5C, F) and beta III 
tubulin, a marker for young neurons (Figure 5H, K), after 6 days of culture on laminin in 
mitogenic growth factor-free culture media. A subset of the culture maintained nestin 
expression in both labeled and unlabeled NPSCs after 6 days of culture on laminin in 
mitogenic growth factor-free media indicating retention of neural progenitor phenotype 
(Figure 5I, L). Minimal Olig2 expression was observed for both labeled and unlabeled 
NPSCs under these culture conditions as expected based on previous work1.
Labeled NPSCs can be detected by MR and fluorescence
Calibration curves obtained for the PDMS nanoemulsion displayed high pO2 sensitivity with 
a linear dependence (R2>0.98) of R1 on pO2 at 23 °C and 33.5 °C with slopes of (1.30 ± 
0.08)×10−3 (torr s)−1 and (1.25 ± 0.01)×10−3 (torr s)−1 respectively (Supplementary Figure 
3). The intercepts (representing the anoxic relaxation rate) were 0.235 ± 0.006 s−1 and 0.207 
± 0.001 s−1 at 23 °C and 33.5 °C respectively, which corresponds to a range of 4.3–4.8 s.
Figures 6 and 7 show the dual-modality imaging of the labeled NPSCs using a siloxane-
selective MRI with the PISTOL sequence and fluorescence imaging. In the case of MR 
imaging of phantoms 1 and 2 (Figure 6), 10-fold lower signal-to-noise ratio (SNR) was 
observed for phantom 2 (SNR ~ 12.6, 64 signal averages, total imaging time = 3 min 12 s) 
when adjusted for the effect of number of signal averages, compared to phantom 1 
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(SNR~15.4, 1 signal average). Due to imaging time limitations, pO2 measurements were not 
performed on these two phantoms. Using fluorescence imaging, a 7 fold lower signal-to-
noise ratio (SNR) was obtained for phantom 2 (SNR~ 151) compared to phantom 1 
(SNR~1000). In the case of phantom 3, siloxane selective imaging with PISTOL allowed 
detection and oximetry of cells with mean pO2 value of 94±67 torr (Figure 7) for the pellet. 
MRSI also allowed the visualization of the labeled cells. The SNR for the proton density 
weighted PISTOL image (Figure 7B) was 12.3 while that of the MRSI chemical shift image 
(Figure 7E) was 38.6. In all cases fluorescence imaging easily showed the presence of 
labeled NPSCs and images from the two modalities were well correlated.
DISCUSSION
Cell-based therapies are a promising treatment strategy for a variety of clinical problems, 
ranging from degenerative diseases to cancer. However, the translation of cell-based 
therapies to the clinic has stalled largely due to questions related to efficacy and safety11. In 
moving from preclinical to clinical studies, the ability to critically analyze the fate and 
functional effects attributed to cell-based therapeutics is drastically limited due to the lack of 
non-invasive, nondestructive monitoring techniques. This major limitation has been 
identified by the California Institute of Regenerative Medicine and other agencies as a key 
obstacle in efforts to move stem cell therapies into the clinic4. Thus, the underlying 
mechanisms regarding the success or failures of such therapies in the clinic remain unclear. 
Development of effective cell labeling and non-invasive tracking methods would greatly 
facilitate the ability to monitor cell dynamics in vivo and evaluate the impact of cell 
therapies.
Improved detection of labeled cells could possibly be achieved using higher cell counts or 
increasing the amount label within a cell using longer incubation times or higher labeling 
concentration. However, this might have implications on cellular functionality. Our 
rhodamine doped PDMS-core nanoemulsion was found to effectively label NPSCs at a 
concentration of 10 μL/104 cells with robust fluorescent labeling retention out to 6 days 
(Supplementary Figure 1). These results are comparable to previous reports on 
superparamagnetic iron oxide (SPIO) particle labeling of NPSCs16. Labeling at 10 μL/104 
cells maintained 80.1% NPSC viability (Figure 2), which is comparable to post-labeling 
viability in previous efforts to label NPSCs for non-invasive imaging with magnetic 
nanoparticles26 and 19F labeling agents7. We acknowledge that a post-labeling viability of 
80% is less than optimal and thus continued experimentation with labeling parameters will 
be considered in future work to address this minor constraint.
Maintaining high viability is not, in itself, sufficient for effective cell labeling. NPSC 
behaviors such as proliferation, migration and differentiation are critical to the efficacy of 
NPSC transplant therapies, thus the effect of labeling techniques on these behaviors must be 
taken into account. Moreover, the mechanistic ambiguity surrounding cell therapy 
necessitates that the effects of labeling techniques on cellular behavior remain negligible. 
Labeling with PDMS nanoemulsion did not significantly affect NPSC proliferation, radial 
migration or capacity for differentiation into cell types of the CNS compared to unlabeled 
NSPCs (Figures 3–5) after 6 days in culture. While several published labeling techniques 
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have effectively conserved NPSC function, limited functionality of SPIO labeled cells in 
vivo has recently been reported by Cromer Berman et al10. Specifically, reduced migration 
of SPIO labeled NPSCs was observed compared to unlabeled NPSCs after transplantation in 
vivo, where early exocytosis of the particles appeared to allow for recovery of NPSC 
migration10. While PDMS labeled NPSC migration has not yet been investigated in vivo, the 
robust radial migration observed by labeled NPSCs in vitro without loss of labeling as 
observed for SPIO-labeled NPSCs indicates that PDMS labeling does not negatively affect 
NPSC migration and provides encouragement for forthcoming in vivo experimentation.
Dual-modality imaging and oximetry of labeled NPSCs was successfully demonstrated 
using 1H MRI and fluorescence imaging for as low as 105 cells at 7T field (Figure 7). The 
individual SNR observed in each experiment indicate that further reduction of cell number 
would still allow detection within clinically acceptable imaging times (<10 min) but 
oximetry may be challenging. Surprisingly the SNR for the phantom with the least number 
of cells (phantom #3) was comparable to the other two phantoms with 4 times (phantom 1) 
and 9.5 times (phantom 2) as many cells. This implies that for future in vitro or in vivo 
studies, factors such as coil position relative to transplanted cells and coil tuning may be as 
critical for successful imaging and oximetry as efficient labeling. Furthermore, factoring in 
the acquisition time difference of 6.5 fold between the two sequences used for phantom 3, 
the PISTOL sequence would be theoretically expected to yield a SNR of 31.3 (compared to 
38.6 for the MRSI sequence) for the same imaging time as the MRSI acquisition under these 
conditions. This indicates that the sensitivity of the PISTOL technique is only slightly lower 
than the MRSI. While the EPI based PISTOL has stricter limitation on minimum echo time, 
the SNR of the MRSI data could be improved by reduction in the echo time used. With the 
development of accelerated MRI data acquisition methods based on compressed sensing23,34 
and advanced radiofrequency coils for MRI22,25,32, we can expect improved sensitivity of 
this and other positive contrast cell labeling techniques (such as using 19F based probes2). 
Recently, Ahrens et al. have successfully imaged 107 perfluorocarbon emulsion-labeled 
dendritic cells in colorectal adenocarcinoma patients at 3T field with a custom-built surface 
coil2, which is a promising development from the point-of-view of application of our 
analogous 1H MR technique. It is important to note that recent developments using MPIOs 
for cell tracking14 may enable detection and tracking of very small number of cells. While 
these particles cannot report on cellular pO2, they show great potential for time-course 
migration studies with high resolution MRI if migration rates (not reported) remain 
unaltered with labeling.
Similar to perfluorocarbon based probes, oximetry of labeled cells by 1H MR using 
siloxane-core nanoprobes requires mapping of the T1 recovery time19. This currently takes 
3.5 min using PISTOL assuming 1 signal average for the image acquired with the longest 
recovery time20. This long recovery time may pose a problem at low labeled-cell densities 
where signal to noise for a single shot acquisition may be <2.5 thus potentially hindering 
imaging and oximetry. For example, given that oximetry using PISTOL (with 1 average for 
the longest TR) takes 3.5 min, that for phantom 2 (with an SNR of 12.6 with 64 averages) 
would take 3 hrs and 44 min. In such cases, faster pulse-sequences will be needed to 
complete oximetry in clinically reasonable times. We recently reported31 a faster version of 
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the PISTOL technique, that allows a temporal resolution of 1 min for oximetry using 
hexamethyldisiloxane (anoxic T1~ 11 s). With PDMS, (anoxic T1< 5 s) this new technique 
could perform single shot oximetry in 25s, thus allowing for signal averaging. In the present 
study, in vitro oximetry of labelled NPSC pellet (phantom 3) yielded a mean pO2 value and 
range (94±67 torr) which is similar to that seen in case of MCF7 cells four hours after 
sealing the phantom24. While in vivo oximetry was not demonstrated in our study, we note 
that Zhong et al. successfully reported intracellular pO2 measurements from labeled tumor 
cells in vivo and observed a transient spike in pO2 following T-cell immunotherapy and 
putative tumor cell death33. Although, in this case, the target-cells were labeled as opposed 
to the therapeutic cells, this study highlights the importance of non-invasive, multifunctional 
tracking of cell therapy.
With any cell labeling technique, dilution of the intracellular label by cell division can 
potentially limit detection in the long-term. Internalization of the label nanoprobes by 
macrophages at the transplant site may obfuscate mechanistic interpretation of signal 
intensity time course from non-invasive imaging data. In this regard, the proposed technique 
has limitations equivalent to those of other positive or negative contrast cell-labeling 
techniques in development or clinical use4.
In conclusion, we have successfully demonstrated in vitro labeling, imaging and oximetry of 
NPSCs using PDMS-based dual modality (MRI/fluorescence) nanoprobes with the potential 
for dual functionality (contrast/oximetry). Future work will aim to apply these nanoprobes to 
tracking implanted cells in vivo while simultaneously monitoring cell health via 1H MR 
oximetry. The non-invasive nature of an MR based approach to cell tracking allows for 
increased applicability compared to destructive methods of cell tracking. As such, this tool 
has the potential to provide mechanistic insight into current therapies, allowing for informed 
innovation and improvement; and to guide the precise design of future cell therapies due to 
its clinical translatability.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Nanoprobe fabrication process of PDMS/Rhodamine B-loaded emulsions. HS 15 emulsifier 
encapsulates PDMS/Rhodamine B in aqueous solution. Nanoemulsions are formed through 
sonication and then filtered to exclude larger particles. Dynamic light scattering (DLS) data 
indicate that particles range from 50–150 nm in diameter after filtration, number-weighted 
average is 98 ± 28 nm (average of 8 samples).
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Figure 2. 
NPSC viability after nanoemulsion labeling. Percent viability decreased as a function of 
labeling concentration, observed as a calcein AM negative NPSC population through flow 
cytometry (A). Effective labeling, determined through fluorescent microscopy, was not 
observed at 1 or 5 μL/104 cells compared to unlabeled NPSCs (AC) but was detectable in 
NPSCs labeled at 10 and 50 μL/104 cells (D, E). Fluorescent imaging of calcein AM 
positive NPSCs supports flow cytometry data where viability is well preserved up to 50 
μL/104 cells, at which point it decreases substantially. Scale bars are 50 μm.
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Figure 3. 
NPSC proliferation on poly-L-lysine (PLL) at 6 days as determined through PicoGreen 
dsDNA quantification. Cell counts were not significantly different after 6 days of culture on 
PLL between labeled and unlabeled NPSCs (p=0.0950). Cell counts were calculated based 
on a cell standard and normalized to baseline measurements at taken day 0.
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Figure 4. 
NPSC radial migration on poly-L-lysine (PLL) and laminin out to 6 days. NPSC radial 
migration was quantified through diametrical measurements at days 3 and 6 normalized to 
baseline measurements taken at day 0(A). Both labeled and unlabeled NPSC radial 
migration significantly increased on laminin at days 3(B) and 6(C) compared to labeled and 
unlabeled PLL controls, respectively. No significant differences were observed between 
radial migration of unlabeled and labeled NPSCs on laminin at 3 (B) and 6 (C) days. 
*p<0.01 compared to unlabeled NPSC migration on laminin, #p<0.01 compared to labeled 
NPSC migration on laminin.
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Figure 5. 
NPSCs retain capacity for differentiation out to 6 days after labeling as compared to 
unlabeled NPSCs. Labeled cells, indicated by positive rhodamine signal (A, G), stained 
positive for markers of astrocytes (GFAP,B), young oligodendrocytes (Olig2,C) and young 
neurons (β III tubulin, H) in levels comparable to those of unlabeled NPSCs (D–F, J–L). A 
subset of labeled and unlabled cells retained NPSC phenotypic markers as indicated by 
positive nestin staining (I, L, respectively). Scale bar is 150 μm.
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Figure 6. 
Dual-modality (MRI/fluorescence) imaging of labeled NPSC pellet (phantom 1, 4×105 cells) 
(A-C) and labeled NPSCs (phantom 2, 9.5×105 cells) suspended in agarose (D–F). T1-
weighted scout scan of labeled stem cell pellet submerged in agarose gel (A, D), siloxane-
selective proton density PISTOL image overlaid on scout image (B, E), and fluorescence 
(λex/λem = 500 nm/560 nm) image (C, F).
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Figure 7. 
Dual-modality (MRI/fluorescence) imaging and oximetry of labeled NPSC pellet (1×105 
cells) in phantom 3. (A) T1-weighted scout image (B) siloxane-selective proton density 
PISTOL image overlaid on scout image (C) fluorescence (λex/λem = 500 nm/560 nm) image, 
(D) water-suppressed NMR spectra of high intensity voxel in the metabolite map, (E) 
chemical shift image (0 ppm) overlaid on scout image, and (F) pO2 map overlaid on scout 
image.
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